Weight Management Peptides
Wholesale Weight Management Peptide Supply
Weight management peptides are among the fastest-growing compounds in the global wellness market. Driven by widespread interest in metabolic health, fat loss research, and GLP-1 receptor agonist science, demand from clinics, supplement brands, and wholesale distributors has grown substantially year-over-year.
Peptide Direct supplies three flagship weight management compounds — AOD-9604, Cagrilintide, and Retatrutide — at wholesale volumes with full quality documentation.
Our Weight Management Peptide Range
Each compound is verified by HPLC analysis to a minimum purity of ≥98%. Every batch ships with a Certificate of Analysis (CoA).
| Compound | Primary Mechanism | Purity | Form | Supply |
|---|---|---|---|---|
| AOD-9604 | Fat metabolism & body composition support | ≥98% HPLC | Lyophilised powder | Wholesale & bulk |
| Cagrilintide | Amylin receptor agonism, appetite regulation & weight loss | ≥98% HPLC | Lyophilised powder | Wholesale & bulk |
| Retatrutide | Triple receptor agonism (GIP, GLP-1, glucagon) for weight management | ≥98% HPLC | Lyophilised powder | Wholesale & bulk |
AOD-9604
AOD-9604 (Advanced Obesity Drug-9604) is a modified synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), corresponding to amino acids 176–191. It has been studied for its role in stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat formation) without the insulin-related effects associated with full-length hGH. AOD-9604 is widely supplied to weight management clinics, metabolic wellness brands, and body composition research distributors worldwide.
| Property | Detail |
|---|---|
| Compound Name | AOD-9604 |
| Full Name | Advanced Obesity Drug-9604 |
| Classification | Human Growth Hormone (hGH) Fragment Analogue |
| Peptide Type | Modified hGH Fragment Peptide |
| Structure | Synthetic fragment derived from the C-terminal region of hGH, amino acids 176–191 |
| Molecular Formula | C78H123N23O23S2 |
| Molecular Weight | Approximately 1815 g/mol |
| Purity | ≥98% HPLC verified |
| Form | Lyophilised powder |
| Supply | Wholesale & bulk available |
Cagrilintide
Cagrilintide is a long-acting synthetic analogue of amylin, a peptide hormone co-secreted with insulin from pancreatic beta cells. It acts as an amylin receptor agonist, working to reduce appetite, slow gastric emptying, and support weight loss through central and peripheral mechanisms. Cagrilintide has been studied in combination with semaglutide (as CagriSema) in clinical trials, demonstrating significant weight reduction results. It is one of the most commercially compelling next-generation weight management compounds available for wholesale supply.
| Property | Detail |
|---|---|
| Compound Name | Cagrilintide |
| Classification | Long-Acting Amylin Receptor Agonist |
| Peptide Type | Synthetic Amylin Analogue |
| Mechanism | Amylin receptor agonism — appetite regulation, gastric emptying, and weight management |
| Also Studied As | CagriSema (in combination with semaglutide) |
| Purity | ≥98% HPLC verified |
| Form | Lyophilised powder |
| Supply | Wholesale & bulk available |
Retatrutide
Retatrutide is a synthetic triple receptor agonist that simultaneously targets GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. This triple agonist mechanism distinguishes it from dual agonists such as tirzepatide and single agonists such as semaglutide, and has demonstrated significant weight reduction results in Phase 2 clinical trials. Retatrutide is one of the most closely watched next-generation metabolic compounds in the research and commercial wellness market, with strong and growing demand from clinics and distributors seeking to stay ahead of the curve.
| Property | Detail |
|---|---|
| Compound Name | Retatrutide |
| Also Known As | LY3437943 |
| Classification | Triple Receptor Agonist (GIP / GLP-1 / Glucagon) |
| Peptide Type | Synthetic Incretin-Based Peptide |
| Mechanism | Simultaneous agonism of GIP, GLP-1, and glucagon receptors for metabolic and weight management support |
| Clinical Stage | Phase 2 clinical trials completed (as of research cutoff) |
| Purity | ≥98% HPLC verified |
| Form | Lyophilised powder |
| Supply | Wholesale & bulk available |
Why Source Weight Management Peptides from Peptide Direct?
Peptide Direct is a specialist wholesale supplier — not a retail operation. Our infrastructure is built for the volume, documentation, and reliability requirements of commercial buyers.
- Verified purity on every batch — HPLC analysis with CoA provided on all orders
- GMP & ISO 9001:2015 certified manufacturing — HACCP protocols applied across the supply chain
- Private label & custom packaging — custom-branded vials and packaging available for qualifying buyers. Learn more about private label
- Global fulfilment — reliable international distribution to clinics, distributors, and brands worldwide
- Flexible order volumes — scalable supply arrangements for businesses of all sizes
- Dedicated vendor support — account management built specifically for peptide vendors and resellers
Frequently Asked Questions
What are weight management peptides?
Weight management peptides are synthetic compounds studied for their role in fat metabolism, appetite regulation, and metabolic health. Key compounds include AOD-9604 (hGH fragment for fat metabolism), Cagrilintide (amylin receptor agonist for appetite regulation), and Retatrutide (triple receptor agonist targeting GIP, GLP-1, and glucagon pathways).
What is the difference between AOD-9604, Cagrilintide, and Retatrutide?
AOD-9604 is a fragment of human growth hormone studied primarily for lipolysis and fat metabolism. Cagrilintide is a long-acting amylin analogue that works through appetite suppression and gastric motility modulation. Retatrutide is a triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously — the broadest mechanism of action of the three, and the most advanced in terms of clinical development.
What is Retatrutide and how does it differ from semaglutide?
Retatrutide is a triple agonist (GIP, GLP-1, glucagon), whereas semaglutide is a single GLP-1 receptor agonist. The additional glucagon and GIP receptor activity in Retatrutide is associated with greater energy expenditure and weight reduction in pre-clinical and Phase 2 clinical data. It is considered one of the next-generation alternatives to current GLP-1 therapies.
What purity standards do your weight management peptides meet?
All weight management peptides supplied by Peptide Direct meet a minimum purity of ≥98% verified by HPLC analysis. Every batch is accompanied by a Certificate of Analysis and produced under GMP and ISO 9001:2015 certified conditions. See our Quality Assurance page for full details.
Do you supply weight management peptides at wholesale volumes?
Yes. We supply AOD-9604, Cagrilintide, and Retatrutide at bulk and wholesale volumes to clinics, wellness brands, distributors, and resellers globally. Visit our Wholesale page or contact us to discuss minimum order quantities and pricing.
Can I get private label packaging for weight management peptides?
Yes. We offer full private label and custom branding solutions for all weight management peptides, including custom-branded vials, outer packaging, and labelling. Available to qualifying wholesale buyers. See our Private Label page for more information.
Do you ship weight management peptides internationally?
Yes. Peptide Direct supplies weight management peptides to wholesale buyers across Europe, North America, Asia-Pacific, and beyond. Contact us to discuss shipping to your location.
For research and laboratory purposes only. Not intended for human consumption, medical use, diagnosis, treatment, cure, or prevention of any disease. Products sold by Peptide Direct are intended exclusively for qualified research professionals and licensed institutions. Buyers are responsible for ensuring compliance with all applicable laws and regulations within their jurisdiction.